‹ Screener

Instil Bio, Inc.

TIL · Biological Products, (No Diagnostic Substances) · 6.8M shares · -20%/yr ↓ buyback · EDGAR filings ↗

Reference price $23.04 · est. market cap ~$156M — last insider sale, 2025-09-10 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D44

Clinical/early-stage biotech — clinical-stage biotech (pivoted), extremely cash-rich.

Strengths

Risks

Notable findings

Quarterly revenue

2021-03-31 · $02021-06-30 · $02021-09-30 · $02021-12-31 · $0

Last 4 quarters · from SEC filings.

Key metrics

Return on equity
-62.7%
Return on assets
-35.1%
Current ratio
39.5×
EBITDA
-$78M
Tangible book value
$114M
Cash & investments
$7M

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2025-09-10Laumas SandeepOption exercise17K$11.60
2025-09-10Laumas SandeepOption exercise13K$12.68
2025-09-10Laumas SandeepSell18K$23.04
2025-09-10Laumas SandeepSell12K$23.88

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-11Shareholder votefiling ↗
2026-05-15ResultsExhibitsfiling ↗
2026-04-03Auditor changeExhibitsfiling ↗
2026-03-27ResultsExhibitsfiling ↗
2026-01-061.02filing ↗
2025-11-13ResultsExhibitsfiling ↗
2025-08-13ResultsExhibitsfiling ↗
2025-07-31Otherfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-112026-06-110001789769-26-000048 ↗
10-Q2026-05-152026-03-310001789769-26-000045 ↗
8-K2026-05-152026-05-150001789769-26-000044 ↗
8-K2026-04-032026-04-010001789769-26-000024 ↗
10-K2026-03-272025-12-310001789769-26-000019 ↗
8-K2026-03-272026-03-270001789769-26-000018 ↗
8-K2026-01-062026-01-050001789769-26-000004 ↗
10-Q2025-11-132025-09-300001789769-25-000094 ↗
8-K2025-11-132025-11-130001789769-25-000092 ↗
8-K2025-08-132025-08-130001789769-25-000079 ↗
10-Q2025-08-132025-06-300001789769-25-000081 ↗
8-K2025-07-312025-07-310001789769-25-000074 ↗